Pfizer locks in long runway for blockbuster heart drug after key patent settlements
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Subscribe To Our Newsletter & Stay Updated